Peptic ulcer rebleeding in patients with and without chronic kidney disease
DOI:
https://doi.org/10.24265/horizmed.2018.v18n4.03Keywords:
Peptic ulcer, Chronic kidney disease, ComplicationsAbstract
Objective: To determine if rebleeding in peptic ulcer disease (PUD) in patients with chronic kidney disease (CKD) is greater than in patients without CKD hospitalized in the Digestive Bleeding Unit of the Hospital Nacional Edgardo Rebagliati Martins. Materials and methods: An observational, analytical, retro-prospective, case-control study was performed in patients >18 years with rebleeding in PUD, admitted to the Digestive Hemorrhage Unit of the Hospital Nacional Edgardo Rebagliati Martins during 1 year. Results: Out of 146 patients, 26 % were female and 74 % were male. The mean age was 65.47 ± 17.95 years. The cases (PUD with CKD) consisted of 34 patients and the controls (PUD without CKD) consisted of 112 patients. The causes of rebleeding were duodenal ulcer (53 %) and gastric ulcer (47 %). The odds ratio (OR) of rebleeding in patients with CKD was 6.43 times higher than in patients without CKD. Rebleeding in patients with CKD was 41.1 % and in patients without CKD it was 9.8 %. The type of ulcer with the greatest rebleeding was type IIa in both groups. Ninety-four percent (94 %) of the patients were discharged, and 2.7 % were referred to surgery. The total mortality rate was 2.7 %, and the mortality rate in patients with CKD was 5.8 % (p = 0.2). Conclusions: The OR of peptic ulcer rebleeding in patients with CKD is 6.43 times higher than in patients without CKD. Rebleeding in peptic ulcer disease in patients with CKD was 41.1 %, whereas in patients without CKD it was 9.8 %.
Downloads
References
Saad R, Scheiman J. Diagnosis and management of peptic ulcer disease. Clin Fam Pract. 2004;6(3): 569-87.
Goicoechea E, Chian A. Características clínico epidemiológicas de la enfermedad renal crónica en pacientes con hipertensión arterial y/o diabetes mellitus II. Hospital I Albrecht – Essalud, 2008. UCV. Scientia. 2010; 2(2); 61-72.
Parasa S, Navaneethan U, Sridhar AR, Venkatesh PG, Olden K. End-stage renal disease is associated with worse outcomes in hospitalized patients with peptic ulcer bleeding. Gastrointest Endosc. 2013; 77(4): 609-16.
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1-130.
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007; 72(3).247-59.
Montes P, Salazar S, Monge E. Epidemiological changes in peptic ulcer and their relation with Helicobacter pylori. Hospital Daniel A Carrion 2000-2005. Rev Gastroenterol Peru. 2007; 27(4):382-8.
Ichiyanagui C, Lozano R, Huamán C, Iparraguirre H. Enfermedad ulcerosa péptica en pacientes cirróticos. Rev Gastroenterol Peru. 1995; 15(1):15-9.
Bang CS, Lee YS, Lee YH, Sung H, Park HJ, Kim HS, et al. Characteristics of nonvariceal upper gastrointestinal hemorrhage in patients with chronic kidney disease. World J Gastroenterol. 2013; 19(43): 7719-25.
Luo JC, Leu HB, Hou MC, Huang KW, Lin HC, Lee FY, et al. Nonpeptic ulcer, nonvariceal gastrointestinal bleeding in hemodialysis patients. Am J Med. 2013; 126(264):e25-e32.
Lin SC, Wu KL, Chiu KW, Lee CT, Chiu YC, Chou YP, et al. Risk factors influencing the outcome of peptic ulcer bleeding in end stage renal diseases after initial endoscopic haemostasis. Int J Clin Pract. 2012; 66(8):774-81.
Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut. 2011; 60(8): 1038-42.
Cheung J, Yu A, LaBossiere J, Zhu Q, Fedorak RN. Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease. Gastrointest Endosc. 2010; 71(1):44-9.
Luo JC, Leu HB, Huang KW, Huang CC, Hou MC, Lin HC, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ. 2011; 183(18): 1345-51.
Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost 2004; 30(5):579–89.
Rockall T, Logan R, Devlin H, Northfield T. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996; 38(3):316–21.
Holster IL, Kuipers EJ. Update on the endoscopic management of peptic ulcer bleeding. Curr Gastroenterol Rep. 2011; 13(6):525–31.
Nardone G, Rocco A, Fiorillo M, Del Pezzo M, Autiero G, Cuomo R, et al. Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure. Helicobacter. 2005 10(1):53-8.
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
